Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 00:00 | 01 Mar | 20.35 |
0.40 (2.01%) |
OPEN
20.55 |
HIGH
21.00 |
LOW
20.25 |
NSE 00:00 | 01 Mar | 20.35 |
0.25 (1.24%) |
OPEN
20.30 |
HIGH
20.95 |
LOW
20.20 |
OPEN | 20.55 |
PREVIOUS CLOSE | 19.95 |
VOLUME | 51696 |
52-Week high | 30.05 |
52-Week low | 7.20 |
P/E | |
Mkt Cap.(Rs cr) | 456 |
Buy Price | 20.35 |
Buy Qty | 391.00 |
Sell Price | 20.65 |
Sell Qty | 576.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Cash Flow
Figures in Rs crore | 2020 | 2019 | 2018 |
Opening Cash & Cash Equivalents | 20.58 | 8.91 | 12.81 |
Net Cash From Operating Activities | 285.65 | 238.89 | 65.14 |
Net Cash Used In/from Investing Activities | -33.14 | -26.13 | -29.44 |
Net Cash Used In/from Financing Activities | -251.86 | -201.09 | -39.60 |
Net (decrease)/increase In Cash and Cash Equivalents |
0.65 | 11.67 | -3.90 |
Closing Cash & Cash Equivalents | 21.23 | 20.58 | 8.91 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices